Cargando…

The breast cancer immune microenvironment is modified by neoadjuvant chemotherapy

Neoadjuvant chemotherapy (NAT) in breast cancer (BC) has been used to reduce tumor burden prior to surgery. However, the impact on prognosis depends on the establishment of Pathological Complete Response (pCR), which is influenced by tumor-infiltrating lymphocyte levels and the activation of the ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Urueña, Claudia, Lasso, Paola, Bernal-Estevez, David, Rubio, Diego, Salazar, Ana Janeth, Olaya, Mercedes, Barreto, Alfonso, Tawil, Mauricio, Torregrosa, Lilian, Fiorentino, Susana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106657/ https://www.ncbi.nlm.nih.gov/pubmed/35562400 http://dx.doi.org/10.1038/s41598-022-12108-5

Ejemplares similares

Evaluation of chemotherapy and P2Et extract combination in ex-vivo derived tumor mammospheres from breast cancer patients
por: Urueña, Claudia, et al.
Publicado: (2020)

Phyto-Immunotherapy, a Complementary Therapeutic Option to Decrease Metastasis and Attack Breast Cancer Stem Cells
por: Fiorentino, Susana, et al.
Publicado: (2020)

Modulation of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment by Natural Products
por: Calderon, Jhon Jairo, et al.
Publicado: (2023)

Breast Tumor Cells Highly Resistant to Drugs Are Controlled Only by the Immune Response Induced in an Immunocompetent Mouse Model
por: Lasso, Paola, et al.
Publicado: (2019)

Tillandsia usneoides Extract Decreases the Primary Tumor in a Murine Breast Cancer Model but Not in Melanoma
por: Lasso, Paola, et al.
Publicado: (2022)

Prophylactic vs. Therapeutic Treatment With P2Et Polyphenol-Rich Extract Has Opposite Effects on Tumor Growth
por: Lasso, Paola, et al.
Publicado: (2018)

An Immunomodulatory Gallotanin-Rich Fraction From Caesalpinia spinosa Enhances the Therapeutic Effect of Anti-PD-L1 in Melanoma
por: Lasso, Paola, et al.
Publicado: (2020)

Plant extract from Caesalpinia spinosa inhibits cancer-associated fibroblast-like cells generation and function in a tumor microenvironment model
por: Jiménez, Maria Camila, et al.
Publicado: (2023)

Safety and efficacy of P2Et extract from Caesalpinia spinosa in breast cancer patients: study protocol for a randomized double blind phase II clinical trial (CS003-BC)
por: Ballesteros-Ramírez, Ricardo, et al.
Publicado: (2023)

Piper nigrum extract suppresses tumor growth and enhances the antitumor immune response in murine models of breast cancer and melanoma
por: Lasso, Paola, et al.
Publicado: (2023)

Safety Evaluation in Healthy Colombian Volunteers of P2Et Extract Obtained from Caesalpinia spinosa: Design 3+3 Phase I Clinical Trial
por: Duran, María I, et al.
Publicado: (2022)

Petiveria alliacea Reduces Tumor Burden and Metastasis and Regulates the Peripheral Immune Response in a Murine Myeloid Leukemia Model
por: Murillo, Natalia, et al.
Publicado: (2023)

Immune system activation through immunogenic cell death and tumor recruitment of dendritic cells is required for anti-tumor activity of a plant-derived polyphenol rich fraction
por: Gomez-Cadena, Alejandra, et al.
Publicado: (2015)

Neoadjuvant chemotherapy modulates exhaustion of T cells in breast cancer patients
por: Rodríguez, Ivon Johanna, et al.
Publicado: (2023)

Circulating Proteins Associated with Response and Resistance to Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer
por: Chantada-Vázquez, María del Pilar, et al.
Publicado: (2022)

Doxorubicin Activity Is Modulated by Traditional Herbal Extracts in a 2D and 3D Multicellular Sphere Model of Leukemia
por: Corzo Parada, Laura, et al.
Publicado: (2023)

Reprograming the tumor immunologic microenvironment using neoadjuvant chemotherapy in osteosarcoma
por: Deng, Chuangzhong, et al.
Publicado: (2020)

The effect of neoadjuvant chemotherapy on the tumor immune microenvironment in gastrointestinal tumors
por: Wang, Yujie, et al.
Publicado: (2022)

Racial disparity in tumor microenvironment and distant recurrence in residual breast cancer after neoadjuvant chemotherapy
por: Kim, Gina, et al.
Publicado: (2023)

Determining the use of prophylactic antibiotics in breast cancer surgeries: a survey of practice
por: Acuna, Sergio A, et al.
Publicado: (2012)

Monitoring the responsiveness of T and antigen presenting cell compartments in breast cancer patients is useful to predict clinical tumor response to neoadjuvant chemotherapy
por: Bernal-Estévez, David A., et al.
Publicado: (2018)

Mechanisms behind prometastatic changes induced by neoadjuvant chemotherapy in the breast cancer microenvironment
por: Perelmuter, Vladimir M, et al.
Publicado: (2019)

The impact of neoadjuvant chemotherapy on the tumor microenvironment in advanced high-grade serous carcinoma
por: Shen, Yuanming, et al.
Publicado: (2022)

Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic and Neoadjuvant Chemotherapy Relevant Signatures
por: Ji, Fei, et al.
Publicado: (2021)

Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response
por: Thompson, Kevin J, et al.
Publicado: (2022)

Reconstruction of the gastric cancer microenvironment after neoadjuvant chemotherapy by longitudinal single-cell sequencing
por: Chen, Yingtai, et al.
Publicado: (2022)

Polyphenol-rich extract induces apoptosis with immunogenic markers in melanoma cells through the ER stress-associated kinase PERK
por: Prieto, Karol, et al.
Publicado: (2019)

Predictive value of improvement in the immune tumour microenvironment in patients with breast cancer treated with neoadjuvant chemotherapy
por: Goto, Wataru, et al.
Publicado: (2018)

Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer
por: Lee, Yong Jae, et al.
Publicado: (2022)

Neoadjuvant Chemotherapy Improves the Immunosuppressive Microenvironment of Bladder Cancer and Increases the Sensitivity to Immune Checkpoint Blockade
por: Luo, Hao, et al.
Publicado: (2022)

Locally-advanced primary neuroendocrine carcinoma of the breast: case report and review of the literature
por: Angarita, Fernando A, et al.
Publicado: (2013)

Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
por: Papaccio, Federica, et al.
Publicado: (2020)

Exploring the safety and efficacy of phytomedicine Petiveria alliacea extract (Esperanza) in patients with metastatic gastrointestinal tumors and acute leukemias: study protocol for a phase Ib/randomized double blind phase II trial (PA001)
por: Ballesteros-Ramírez, Ricardo, et al.
Publicado: (2023)

Immune microenvironment changes induced by neoadjuvant chemotherapy in triple-negative breast cancers: the MIMOSA-1 study
por: Sarradin, Victor, et al.
Publicado: (2021)

Multiomics technologies for comprehensive tumor microenvironment analysis in triple-negative breast cancer under neoadjuvant chemotherapy
por: Wang, Gang, et al.
Publicado: (2023)

Immune system activation by natural products and complex fractions: a network pharmacology approach in cancer treatment
por: Gomez-Cadena, Alejandra, et al.
Publicado: (2020)

Pulmonary Sarcoidosis Activation following Neoadjuvant Pembrolizumab plus Chemotherapy Combination Therapy in a Patient with Non-Small Cell Lung Cancer: A Case Report
por: Fakhri, Ghina, et al.
Publicado: (2017)

Clinical effects of Apatinib combined with DOS neoadjuvant chemotherapy regimen in neoadjuvant chemotherapy for LAGC
por: Zhou, Peng-zhe, et al.
Publicado: (2021)

Effect of neoadjuvant chemotherapy on the immune microenvironment in gastric cancer as determined by multiplex immunofluorescence and T cell receptor repertoire analysis
por: Xing, Xiaofang, et al.
Publicado: (2022)

D2 lymphadenectomy is not only safe but necessary in the era of neoadjuvant chemotherapy
por: Shrikhande, Shailesh V, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_j4n3f6gei7lu8jlm067jcab8lf